Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

PURSUIT: Un Programma Scolastico Tecnologicamente Aumentato per Migliorare le Capacità di Adattamento dei Bambini e Prevenire l'Uso di Sostanze.

5 ottobre 2026 aggiornato da: Natoshia Cunningham, Michigan State University

PURSUIT: Un programma scolastico potenziato tecnologicamente per migliorare le capacità di coping dei bambini e prevenire l'uso di sostanze.

The study investigators aim to test an online support platform for Michigan youth aged 8-18 years enrolled in elementary, middle, or high school and their parent/caregiver. The online support platform will be hosted on the Computerized Intervention Authoring System (CIAS) 3.0 and will provide evidence-based cognitive behavioral coping skills for physical (pain) and mental (stress, mood) health symptoms, with additional substance use prevention content for youth aged 12 and older. Evaluations will occur at baseline and then a post assessment approximately 8 weeks later.

Panoramica dello studio

Descrizione dettagliata

The study investigator's aims are to:

  1. Evaluate the feasibility and acceptability of the PURSUIT online support platform using mixed methods.
  2. Explore the impact of PURSUIT on youth's physical (pain) and mental health (stress, anxiety, mood, perceived risk of substance use) symptoms at post assessment.

Consented youth will complete a baseline assessment (week 1), and then will use the PURSUIT online platform (expected duration is 6 week), and complete a post assessment (week 8).

Within the PURSUIT platform, all youth will have access to tools teaching cognitive-behavioral strategies for managing mood, anxiety, stress, and physical pain. Youth aged 12 and older will have access to additional content presenting cognitive-behavioral strategies for reducing the risk of substance use.

Youth will provide data on their symptoms (e.g thoughts, mood, behaviors, sleep, pain, and stress) at baseline and post assessment. A caregiver will report on the child's demographics, adverse childhood experience (ACE) exposure, school performance/attendance and their own mood. At post-assessment, the youth will also be asked to take part in a brief, semi-structured interview regarding their experiences with PURSUIT.

Tipo di studio

Interventistico

Iscrizione (Stimato)

100

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

  • Nome: Natoshia R Cunningham, PhD
  • Numero di telefono: 845-662-6198
  • Email: natoshia@msu.edu

Backup dei contatti dello studio

Luoghi di studio

    • Michigan
      • Grand Rapids, Michigan, Stati Uniti, 49503
        • Michigan State University

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 8 anni a 18 anni (Bambino, Adulto)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Aged eight to 18 years
  • Enrolled in a Michigan elementary, middle, or high school

Exclusion Criteria:

  • Age under 8
  • Age over 18 years
  • Non-enrollment in A Michigan school.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Prevenzione
  • Assegnazione: N / A
  • Modello interventistico: Assegnazione di gruppo singolo
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: PURSUIT Self-Management Portal

All youth enrolled in the study will have access to an online self-management platform, hosted by the Computerized Intervention Authoring System (CIAS). The self-management platform comprises evidence-based cognitive-behavioral psycho-education and skills broadly applicable to physical (pain) and mental (stress, mood) health symptoms. Youth aged twelve and older will have access to content related to preventing substance use. Materials include instructional videos, handouts, and worksheets.

PURSUIT is an online self-management platform for youth aged 8-18 and one caregiver that provides cognitive-behavioral coping skills for physical and mental health symptoms, plus substance use prevention content for youth aged 12 and older.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
PURSUIT Feasibility-Youth Retention
Lasso di tempo: From baseline to post assessment, approximately 8 weeks

The percentage of youth who complete a post-assessment measure, relative to those who complete a baseline assessment.

From baseline to post assessment, approximately 8 weeks
PURSUIT Feasibility/Acceptability
Lasso di tempo: From baseline to post-assessment, approximately 8 weeks.

Youth will complete a brief, semi-structured interview following a six-week period of engagement with the online self-management portal to assess the feasibility ("Do you think you will be able to integrate these skills into your schedule with school/work?") and acceptability of PURSUIT.

From baseline to post-assessment, approximately 8 weeks.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Changes in pain, as measured by the Pain Visual Analog Scale (VAS)
Lasso di tempo: From baseline to post-assessment, approximately 8 weeks.

Youth will report their average pain intensity over the past two weeks using a Visual Analog Scale (VAS). Responses range from 0 (no pain) to 10 (worst imaginable pain), with ratings ≥ 3 indicating moderate pain.

From baseline to post-assessment, approximately 8 weeks.
Change in functional disability, measured using the Functional Disability Inventory (FDI)
Lasso di tempo: From baseline to post-assessment, approximately 8 weeks.

The 15-item FDI assesses youths' difficulty performing tasks across home, school, recreational, and social settings over the "past few days" due to physical symptoms. Items are rated from 0 ("no trouble") to 4 ("impossible") and summed, yielding total scores of 0-60 with scores ≥7 suggesting greater than minimal disability

From baseline to post-assessment, approximately 8 weeks.
Changes in post-traumatic stress disorder symptoms (PTSD), measured using the UCLA Reaction Index for DSM-5 Brief Screening Form
Lasso di tempo: From baseline to post-assessment, approximately 8 weeks.

The UCLA Reaction Index for DSM-5 Brief Screening Form is an 11-item measure of how often youth experienced psychological stress and physiological reactivity due to internal or external trauma reminders, intrusive trauma-related memories, avoidance of internal and external reminders of trauma, emotional dysregulation, attention issues, feelings of detachment, and sleep disturbance over the past month. Items are scored from zero (none of the time) to four (most of the time) and summed; scores of 11-20 suggest mild PTSD symptoms, while scores ≥21 are indicative of potential PTSD. We adapted this measure to not query the type of traumatic exposure experienced by youth. It will only be completed by those who endorse exposure (yes/no) to a frightening or upsetting event.

From baseline to post-assessment, approximately 8 weeks.
Change in anxiety symptoms, measured using the Screen for Child Anxiety Related Disorders (SCARED)
Lasso di tempo: From baseline to post-assessment, approximately 8 weeks.

The 41-item Screen for Child Anxiety Related Disorders (SCARED) assesses past 3-month anxiety symptoms. Items are scored on a 3-point Likert-style scale (0 = not true or hardly ever true, 2=very true or often true), and summed to yield total scores of 0-82 with higher scores indicating greater anxiety and scores ≥25 suggesting clinical significance.

From baseline to post-assessment, approximately 8 weeks.
Change in depressive symptoms, measured using the PROMIS Pediatric Short Form 8a
Lasso di tempo: From baseline to post-assessment, approximately 8 weeks.

Youth will report the frequency (1=never, 5=almost always) of past-week depressive symptoms (e.g., sadness, loneliness) using the eight-item PROMIS Pediatric Depressive Symptoms Short Form 8a. Raw summed scores (range 8 to 40) are converted to T-scores (mean 50, standard deviation 10), with T-scores >55 suggesting mild or higher symptoms.

From baseline to post-assessment, approximately 8 weeks.
Change in fatigue symptoms; as measured by the PROMIS Pediatric Short Form 10a
Lasso di tempo: From baseline to post-assessment, approximately 8 weeks.

Past week fatigue symptoms will be self-reported by youth using the 10-item PROMIS Pediatric Short Form. Items ("Being tired made it hard for me to play or go out with my friends as much as I'd like") are rated on a 5-point Likert-style scale (1=never, 5=almost always) and summed in to total scores, which are converted into T-scores (>55 suggesting at least mild symptoms).

From baseline to post-assessment, approximately 8 weeks.
Change in sleep disturbance symptoms, measured using the PROMIS Pediatric Sleep Disturbance Short Form 8a
Lasso di tempo: From baseline to post-assessment; approximately 8 weeks

The frequency (1=never, 5=almost always) with which youth experienced sleep disturbance symptoms (e.g., trouble falling or staying asleep) in the past week will be assessed using the eight-item PROMIS Pediatric Sleep Disturbance Short Form. T-scores (>55 indicative of mild or greater symptoms) will be derived from summed raw scores.

From baseline to post-assessment; approximately 8 weeks
Change in youths' perceived risk of substance use; measured using Monitoring The Future items
Lasso di tempo: From baseline through post-assessment; approximately 8 weeks.

Youth age 12 and older will report how risky (1= No Risk, 4=Great Risk) they perceive different cigarette, cannabis, alcohol, or vaping use behaviors (e.g., occasional versus regular use) using 12 items from the 2023 Monitoring the Future (MTF) study. MTF is an ongoing longitudinal panel study conducted by the University of Michigan that includes annual surveys of nationally representative samples of 8th, 10,th and 12th grade youth.

From baseline through post-assessment; approximately 8 weeks.
Change in youth's substance use behaviors; assessed using the Screening to Brief Intervention (S2B1)
Lasso di tempo: From baseline through post-assessment; approximately 8 weeks.

The frequency (never, once or twice, monthly, weekly or more often) of past-year nicotine, alcohol, cannabis, and other substance use behaviors will be assessed for youth 12 years and older using the youth-reported Screening to Brief Intervention (S2BI)

From baseline through post-assessment; approximately 8 weeks.
Changes in caregivers' depression, anxiety, and stress as measured by the Depression Anxiety and Stress Scales 21 (DASS21)
Lasso di tempo: From baseline to post-assessment, approximately 8 weeks.

The DASS21 depression, anxiety, and stress on a scale of 0-63 with 0 indicating low levels of these feelings, and 63 indicating high levels. This measure will only be completed by caregivers.

From baseline to post-assessment, approximately 8 weeks.
Change in stress, measured by the PROMIS Pediatric Psychological Stress Experiences 8a
Lasso di tempo: From baseline to post-assessment; approximately 8 weeks

Youth will report how often (1=never, 5=almost always) they experienced feelings of stress over the past week using the eight-item PROMIS Psychological Stress Experiences-Short Form 8a. As per other PROMIS short forms, summed scores are converted to T-scores.

From baseline to post-assessment; approximately 8 weeks
Patient Global Impression of Change
Lasso di tempo: post-assessment; approximately 8 weeks after baseline

A single-item measure completed by the child and caregiver that assesses perceived overall change in the child's status since completing the intervention. Scores range from 1 (Very Much Improved) to 7 (Very Much Worse).

post-assessment; approximately 8 weeks after baseline

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Youth Engagement
Lasso di tempo: From baseline to post-assessment, approximately 8 weeks

The percent of youth who complete at least one activity within the platform, relative to those who complete baseline assessments.

From baseline to post-assessment, approximately 8 weeks
Adverse Childhood Experiences (ACEs)
Lasso di tempo: Baseline

Youth's lifetime exposure to nine ACEs (e.g., violence, household dysfunction) will be reported by caregivers (if age <18) using items adapted from the National Survey of Children's Health.

Baseline
Family Demographic Information
Lasso di tempo: Baseline

Parents/caregivers will report youths' age, sex at birth, racial and ethnic identities, household income, health insurance status/type, and their own highest level of education at baseline.

Baseline
Youth School Attendance
Lasso di tempo: From baseline to post-assessment; approximately 8 weeks

Parent/caregivers will report the frequency with which their child misses or is late to school due to physical and/or mental health symptoms over the past month at baseline and after engaging with the self-management platform

From baseline to post-assessment; approximately 8 weeks
Symptom status and program motivation
Lasso di tempo: baseline

A brief intake questionnaire assessing whether participants experience pain, worries or sad feelings, and stress at baseline and their reasons for participating in the program.

baseline

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 novembre 2026

Completamento primario (Stimato)

1 marzo 2027

Completamento dello studio (Stimato)

1 luglio 2027

Date di iscrizione allo studio

Primo inviato

24 novembre 2025

Primo inviato che soddisfa i criteri di controllo qualità

24 novembre 2025

Primo Inserito (Effettivo)

5 dicembre 2025

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

6 ottobre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

5 ottobre 2026

Ultimo verificato

1 maggio 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • STUDY00011346
  • G-2404-153994 (Altro numero di sovvenzione/finanziamento: Michigan Health Endowment Fund)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

We will not publicly share to protect participant identities but de-identified data may be made available upon reasonable request.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi